Ability of a patient or a Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document
The patient or a legally authorized representative must provide study-specific informed consent prior to step 1 registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry.
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Patients or their legally authorized representative must provide written informed consent
Ability to understand and the willingness to sign a written informed consent document; if a patient has impaired decision-making capacity, a legally authorized representative, patients will be allowed to participate
The subject or the subject's legally acceptable representative provides written, informed consent prior to the initiation of any study procedures.
Documented informed consent of participant and/or legally authorized representative
Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document
Ability to understand and/or the willingness of their parent or legally authorized representative to sign a written informed consent document
Ability of subject or legally authorized representative to understand and the willingness to sign a written informed consent document
DONOR: Ability of subject or legally authorized representative to understand and the willingness to sign a written informed consent document; medically fit and willing to donate
Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document
Must sign study-specific, IRB approved informed consent form prior to study entry. Note consent by legally authorized representative is not allowed for this trial.
Patient (or legally authorized representative) must be able to understand and willing to sign a written informed consent document
Ability to understand and the willingness to sign a written informed consent document. Patients with Impaired Decision Making Capacity (IDMC) can have a Legally Authorized Representative sign on their behalf. Documentation, such as a Power of Attorney, must be presented in order for a substitute decision maker to be allowed
Ability of subject or Legally Authorized Representative (LAR) to understand and the willingness to sign a written informed consent document.
The participant (or legally authorized representative, if applicable) must be willing and able to provide written informed consent for the trial
Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document; for subjects < 18 years old their legal guardian must give informed consent; pediatric subjects will be included in age appropriate discussion and verbal assent will be obtained for those > 7 years of age, when appropriate
Documented informed consent of participant and/or legally authorized representative
Ability of subject or legally authorized representative (LAR) to understand and sign the written informed consent document
Ability of patient or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document
The patient or legally authorized representative must provide study-specific informed consent prior to study entry
Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document
Patients or appropriate legally authorized representatives must possess the ability to give informed consent
Documented informed consent of the participant or legally authorized representative
Patient must have the ability to understand the requirements of the study and signed informed consent. A signed informed consent by the patient or his legally authorized representative is required\r\nprior to their enrollment on the protocol
Patients or their legally authorized representative must provide written informed consent
Documented informed consent of the participant and/or legally authorized representative
Documented informed consent of the subject and/or legally authorized representative
Subject or subject's legally acceptable representative has provided informed consent.
Patients or their legally authorized representative must provide written informed consent
Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document
Able to understand the potential risks, benefits, and requirements of the study and are willing to provide informed consent; an informed consent form for this study that is signed by the patient or his/her legally authorized representative is required prior to enrollment
Able to understand the potential risks, benefits, and requirements of the study and are willing to provide informed consent; an informed consent form for this study that is signed by the patient or his/her legally authorized representative is required prior to enrollment
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must have the ability to understand and provide signed informed written consent
Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Patient or legally authorized representative able to sign informed consent
Patients or their legally authorized representative must provide written informed consent
Patient, legally authorized representative (LAR), or parent able to sign informed consent; able to give assent for patients age 7-17
Patient must have the ability to understand the requirements of the study and signed informed consent a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
Participant has the ability and the willingness to sign the informed consent document (for adults only, for participants with mild cognitive abilities may use a legally authorized representative)
Patient or legally authorized representative able to sign informed consent
RECIPIENT: Ability of subject or legally authorized representative (LAR) (if the patient is deemed by the treating physician to be cognitively impaired or questionably impaired in such a way that the ability of the patient to give informed consent is questionable) to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of this study or written informed consent obtained from parent or legal guardian if subject is a minor
Must sign study-specific, IRB approved informed consent form prior to study entry. Note consent by legally authorized representative is not allowed for this trial.
Patient or legally authorized representative able to sign informed consent
Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
Ability to understand and the willingness to sign a written informed consent document; if the subject is unable to understand the consent due to comorbidity, such as Alzheimer’s disease, consent by a legally authorized representative and assent by the subject will be obtained
Signed informed consent by the patient or legally authorized representative
Voluntary written consent (adult or legally authorized representative; or parental/guardian)
Patient or legally acceptable representative has granted written informed consent before any study specific procedures (including special Screening tests) are performed
Cases involving subjects who are minors, pregnant or require an authorized representative for informed consent
Documented informed consent of the participant and/or the legally authorized representative
Documented informed consent of the participant and/or legally authorized representative
Patient or legally authorized representative able to sign informed consent
Patient must have the ability to understand the requirements of the study and signed informed consent; a signed informed consent by the patient or his legally authorized representative is required prior to their enrollment on the protocol
The patient or a legally authorized representative must provide study-specific informed consent prior to study registration
The patient or a legally authorized representative must provide study-specific informed consent prior to step 1 registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry, including consent for mandatory tumor tissue, serum, and blood submission for immune correlatives (all patients) and p16 analysis (oropharyngeal cases only)
Subjects must be able to understand the nature of this trial and provide written informed consent, prior to any study specific procedures; patients with Impaired Decision Making Capacity (IDMC) who have a close caregiver or legally authorized representative (LAR) may be considered eligible for this study at the treating physician’s discretion, provided that the physician is reasonably sure that the possible risks and benefits of the study are clear and that the patient will take the drug as prescribed
Ability to understand and the willingness to sign a written informed consent document or patients with Impaired Decision Making Capacity (IDMC) if they are represented by a Legally Authorized Representative (LAR)
The participant (or legally acceptable representative if applicable) provides written informed consent for the trial
Patient (or his or her legally accepted representative) has provided written informed consent to participate in the study
Ability to understand and the willingness to sign a written informed consent document (either directly or via a legally authorized representative)
Ability to understand and the willingness to sign a written informed consent document (either directly or via a legally authorized representative)
Subject or his/her legally authorized representative or guardian understands and voluntarily signs an informed consent document prior to any study related assessments/procedures are conducted (except as noted in Section 6).
The patient or a legally authorized representative must provide study-specific informed consent prior to step 1 registration
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Subject or Authorized Representative is unable to provide informed consent.
Patients or their legally authorized representative must provide written informed consent
Be willing and able to provide written informed consent/assent for the trial; consent may be obtained by legally authorized representative (LAR) according to the protocol
Patients or their legally authorized representative must provide written informed consent
Patients or their legally authorized representative must provide written informed consent
Either the subject or his/her legally authorized representative be willing and able to provide written informed consent for the trial
Able to understand and willing to sign a Human Research Protection Office (HRPO) approved written informed consent document (or that of legally authorized representative, if applicable)
Ability to understand and/or the willingness of participant or their parent/legally authorized representative to sign a written informed consent document
Subject must be able to understand and willing to sign an informed consent. A legally authorized representative may consent on behalf of a subject who is otherwise unable to provide informed consent, if acceptable to and approved by the site and/or site's Institutional Review Board (IRB).
Written informed consent, Release of Medical Records Form and HIPAA reviewed and signed by patient or legally authorized representatives
Ability to understand and the willingness to sign a written informed consent document; if the subject is unable to understand the consent due to comorbidity, such as Alzheimer’s disease, consent by a legally authorized representative and assent by the subject will be obtained
PRE-REGISTRATION INCLUSION CRITERIA: Patient (or legally authorized representative) must be able to understand and willing to sign a written informed consent document
Patient (or legally authorized representative) must be able to understand and willing to sign a written informed consent document
The patient must be willing and able to comply with all study protocol requirements. The patient or a legally authorized representative must fully understand all elements of the informed consent and have signed the informed consent according to institutional and federal regulatory requirements
Ability of the patient (or legally authorized representative if applicable) to understand and the willingness to sign a written informed consent document.
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
Able to give informed consent, or their legally authorized representative can give informed consent
Patient, or his/her legally authorized representative, is able to understand and provide informed consent.
Patient or a legally authorized representative of a patient must be able and willing to sign informed consent document that has been approved by an IRB
Patients or their legally authorized representative must provide written informed consent
A written and voluntarily signed informed consent must be obtained from the patient or legally authorized representative, in accordance with local regulations, before the initiation of any study related procedures. The patient or legally authorized representative must be able to read and understand the informed consent form (ICF).
Patient or legally authorized representative able to sign an informed consent form
Patient or legally authorized representative able to sign informed consent
A written and voluntarily signed informed consent must be obtained from the patient or legally authorized representative, in accordance with local regulations, before the initiation of any study related procedures. The patient or legally authorized representative must be able to read and understand the informed consent form (ICF).
Documented informed consent of the participant and/or legally authorized representative
Patients or their legally authorized representative must provide written informed consent
Able to provide informed consent, or if the oncology physician determines the patient to not have decision-making capacity, a patient-designated health care proxy (or authorized representative per institutional policies) must sign consent by the baseline visit; if the participant is found to be impaired on the Blessed-Orientation Memory Concentration Test (BOMC) during screening; they must have a health care proxy or authorized representative to be eligible to enroll
The patient or a legally authorized representative must provide study-specific informed consent prior to study entry
102 Subject or subject's legally acceptable representative has provided informed consent/assent prior to initiation of any study-specific activities/procedures.
Ability to understand and/or the willingness of the patient (or parent or legally authorized representative, if minor) to provide informed consent, using an institutionally approved informed consent procedure
Ability of subject or legally authorized representative (LAR) to understand and the willingness to sign a written informed consent document
SUBJECT: Ability of subject or Legally Authorized Representative (LAR) to understand and willingness to sign a written informed consent document.
Documented informed consent of the participant and/or legally authorized representative
Legally authorized representative consent
Before any study-specific procedure, the appropriate written informed consent must be obtained from the subject or a legally accepted representative.
Subject or authorized representative has provided informed consent.
Participant/parent/legally authorized representative (LAR) unwilling to give written informed consent
Decisionally impaired adults requiring a legally authorized representative
Voluntary written consent signed by the subject (or the subject’s legally authorized representative)
Ability to understand and the willingness to sign a written informed consent document; a legally authorized representative (LAR) may sign informed consent for persons who do not have the capacity to legally consent to take part in the study
Ability of the subject, or the legally authorized representative (LAR) if the patient is deemed by the treating physician to be cognitively impaired or questionably impaired in such a way that the ability of the patient to give informed consent is questionable, to understand, and the willingness to sign, a written informed consent.
Subject or legally authorized representative signs study-related informed consent document
Patient or the patient’s legally authorized representative must provide written informed consent prior to registration and any study-related procedures
Patient or legally authorized representative must be able to understand and willing to sign a written informed consent document
Valid informed consent by subject or subject’s legally authorized representative (LAR)
Patient or patient's legally acceptable representative cognitively provides written informed consent
Patient, or authorized representative signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure
Patient or legally authorized representative must be able to understand and willing to sign a written informed consent document
Patient or legally authorized representative must be able to understand and willing to sign a written informed consent document
Ability of subject or legally authorized representative (LAR) (if the patient is deemed by the treating physician to be cognitively impaired or questionably impaired in such a way that the ability of the patient to give informed consent is questionable) to understand and the willingness to sign a written informed consent document indicating that they are aware of the investigational nature of this study
Patient or the patient’s legally acceptable representative must provide written informed consent prior to registration and any study-related procedures
Patient (or legally authorized representative) must be able to understand and willing to sign a written informed consent document
Patient, or authorized representative signs a written Informed Consent form to participate in the study, prior to any study mandated determinations or procedure
